Compound Library

348+ Compounds. Zero Bro-Science.

Evidence-based profiles across healing peptides, GH secretagogues, GLP-1s, SARMs, steroids, nootropics, supplements, PCT ancillaries, and longevity compounds — with pharmacokinetics, dosing protocols, and outcome data.

Search compounds

Search the compound library by name or alias.

14 of 348 compounds match

Risk is a heuristic, not a medical safety rating. Low does not mean safe.

How these filters work

Risk uses the same estimate as compound profiles: legal status, suppression, ancillary requirements, and anabolic rating. Missing data can fall back to Low.

Routes match any documented option, including experimental or formulation-specific routes. Read each result’s qualifications; matching a route is not a recommendation. Missing or unrecognized routes appear only under All routes.

Goals match an editorial score of at least 6/10 for that dimension, including compounds that qualify for several goals. Missing scores do not match a selected goal. These scores do not measure clinical evidence.

Require PCT shows compounds marked as requiring post-cycle therapy. When off, all compounds are included; an unmarked record does not establish that PCT is unnecessary.

Hair

14

5-AR inhibitors, topical anti-androgens, and vasodilators for retention, regrowth, and follicle health — finasteride, dutasteride, minoxidil, RU58841, pyrilutamide.

Finasteride
Finasteride can slow male pattern hair loss and improve hair counts in some men. It also has sexual, psychiatric and reproductive precautions that need to be di
Recovery 1/1052–520wk

Documented routes: Oral, Topical

Dutasteride
Dutasteride inhibits 5-alpha-reductase and reduces formation of dihydrotestosterone (DHT). Human trials support a hair-growth effect in men with androgenetic al
Recovery 1/1024–260wk

Documented routes: Oral

Minoxidil
Minoxidil is the most reliable hair-growth driver the looksmaxxing community has. Originally a 1970s oral antihypertensive, its hypertrichosis "side effect" tur
Recovery 1/1052–520wk

Documented routes: Topical, Oral

RU58841
RU58841 has become the backbone of serious hair-defense stacks in the looksmaxxing and AAS communities — and for good reason. It's a pure topical androgen recep
Recovery 1/1016–260wk

Documented routes: Topical

Pyrilutamide
Pyrilutamide (KX-826) is a topical androgen-receptor antagonist being developed for androgenetic alopecia. Human studies exist, but their results and reporting
Recovery 1/1024–260wk

Documented routes: Topical

Clascoterone
Why Clascoterone Matters Clascoterone is the first topical androgen receptor antagonist with real Phase 3 data behind it — the molecule that finally drags the
Recovery 2/1012–52wk

Documented routes: Topical

Bimatoprost
Why Bimatoprost Earned Its Spot in the Looksmaxxing Stack Bimatoprost is the most effective topical we have for growing longer, thicker, darker eyelashes and
Recovery 1/1012–52wk

Documented routes: Topical (lid margin, eyebrow, scalp)

GT20029
GT20029 is the first topical AR PROTAC to reach late-stage clinical trials for androgenetic alopecia — and the first genuinely novel mechanism in the hair-loss
Recovery 1/1016–52wk

Documented routes: Topical

AHK-Cu
AHK-Cu is the copper tripeptide that the hair-retention side of the looksmaxxing community reaches for when the goal is specifically follicle trophism — not ski
Recovery 3/1012–52wk

Documented routes: Topical, Intradermal (mesotherapy)

WAY-316606
Overview WAY-316606 is one of the more mechanistically interesting molecules to hit the looksmaxxing hair stack in the last decade. It is a small-molecule ant
Recovery 1/1024–52wk

Documented routes: Topical

Clascoterone
Why Clascoterone Clascoterone is the first topical androgen receptor antagonist with phase 3 data behind it for both acne and androgenetic alopecia — a molecu
Recovery 6/1024–104wk

Documented routes: Topical (cream, hydroalcoholic solution)

Fluridil
What Fluridil Actually Is Fluridil — sold commercially as Eucapil and also called topilutamide — is the only topical antiandrogen with a peer-reviewed, placeb
Recovery 4/1012–52wk

Documented routes: Topical